Niels Nijstad is a Subject Matter Expert in bioanalysis at Ardena. He supports Sponsors in aligning drug development needs with Ardena’s scientific and operational capabilities.
His work focuses on phase-appropriate bioanalytical strategies for drug development programs, including PK, ADA, and biomarker assays. He brings over 15 years of experience across biotech and CRO environments, with expertise at the intersection of translational bioanalysis, regulatory expectations, and business operations.
Niels obtained his PhD from the University of Groningen, where his research focused on cholesterol transport.
